Muscular Dystrophy Animations

What percentage of ALS is genetic?
Up to 90 percent of people with amyotrophic lateral sclerosis (ALS) report that they have no family history of the disease.

Study shows drug lowers levels of biomarker linked to ALS
A new study finds that a decades-old drug used to treat malaria lowers levels of a biomarker linked to the inherited form of amyotrophic lateral sclerosis, also known as ALS and Lou Gehrig's Disease.

One gene closer to regenerative therapy for muscular disorders
A detour on the road to regenerative medicine for people with muscular disorders is figuring out how to coax muscle stem cells to fuse together and form functioning skeletal muscle tissues.

Motor neuron disease discovery offers new insights into potential treatment targets
Scientists have discovered how certain forms of motor neuron disease begin and progress at cellular and molecular levels, revealing potential new ways to slow down or even stop this process.

MS vs. ALS: Differences, causes, and treatment
MS and ALS both affect the central nervous system, but in different ways. Learn about the key differences between the two, specific symptoms, and outlook.

Weekly steroids strengthen and repair muscles
Weekly doses of glucocorticoid steroids, such as prednisone, help speed recovery in muscle injuries, reports a new Northwestern Medicine study.

FDA approves drug to treat ALS
The U.S. Food and Drug Administration approves Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's disease.

Gene silencing shows promise for treating two fatal neurological disorders
In two studies of mice, researchers showed that a drug, engineered to combat the gene that causes spinocerebellar ataxia type 2 (SCA2), might also be used to treat amyotrophic lateral sclerosis...

A new marker for the most common form of ALS
A molecule found in blood and cerebrospinal fluid could serve as an indicator for the most common form of amyotrophic lateral sclerosis (ALS), offering a much needed tool to measure disease...

Occupational exposure to magnetic fields increases risk of ALS
A new study finds that high exposure to extremely low-frequency magnetic fields through work significantly increases the risk of dying from ALS.

'Groundbreaking' technology enables quadriplegic man to move his limbs
Using neuroprosthetic technology, scientists have enabled a man who had been quadriplegic for 8 years to move his limbs and perform daily tasks.

Scientists discover shared genetic origin for ALS/MND and schizophrenia
Researchers have shown for the first time that Amyotrophic Lateral Sclerosis (ALS), also known as Motor Neurone Disease (MND) and schizophrenia have a shared genetic origin, indicating that the...

Researchers identify potential treatment for type of muscle and brain degenerative disease
UCLA researchers have discovered the molecular basis of, and identified potential treatment for, an incurable disease known as inclusion body myopathy, Paget disease with frontotemporal dementia...

New toxic pathway identified for protein aggregates in neurodegenerative disease
Led by professor Ludo Van Den Bosch (VIB-KU Leuven), scientists from Belgium, the UK and the US have identified new processes that form protein "clumps" that are characteristic of amyotrophic...

Caffeine may ward off dementia by boosting protective enzyme
Researchers have uncovered a number of compounds - including caffeine - that boost production of the enzyme NMNAT2, which may protect against dementia.